Anne Armstrong, MRCP, PhD, MB ChB, BSc(Hons), of The Christie Hospital, Manchester, UK, and Nigel Bundred, MD, FRCS, of The University of Manchester, UK, discuss genomic profiling for patients with breast cancer and the Oncotype DX® Breast Cancer Assay.
This content is supported by Genomic Health, Inc.
